Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

F&P Healthcare files patent complaint against rival ResMed

Fisher & Paykel Healthcare has filed a complaint against its rival ResMed, alleging some of ResMed's masks used to treat obstructive sleep apnea infringe its patents.

Auckland-based F&P Healthcare said it has filed a complaint with the US International Trade Commission, alleging the AirFit P10 for Her masks and AirFit P10 for AirMini masks infringe five of its patents and seeking a permanent exclusion order and cease and desist order to prevent the sale and importation of the AirFit P10 range of masks in the US.

“Over the past 20 years, Fisher & Paykel Healthcare has built a significant portfolio of more than 2,000 issued and pending patents," F&P Healthcare managing director Lewis Gradon said in a statement. "We have developed unique mask technology that has provided improved care and outcomes for patients with OSA and we take infringement of our intellectual property rights very seriously.”

F&P Healthcare's action comes hot on the heels of a complaint to the commission from ResMed earlier this month, where the US company sought to ban the importation and sale of F&P Healthcare's Simplus full face mask, Eson nasal mask and Eson 2 nasal mask in the US, and separately lodged a new suit in the US district court accusing the Kiwi firm of patent infringement and seeking damages plus an injunction against future sales of the masks.

The rival companies have been locked in litigation since 2016 spanning the US, UK, Europe, New Zealand and Australia.

F&P Healthcare spent $15.6 million on litigation in the year ended March 31, 2018, down from $20.7 million a year earlier. F&P Healthcare said today its earnings guidance for the 2019 financial year remains unchanged as its latest update on Sept. 3 allowed for legal costs of the latest action. That guidance said the patent dispute would cut annual earnings by as much as $10 million to a range of $205 million to $210 million in the year ending March 31, 2019, from a previous forecast of $215 million.

F&P Healthcare shares slipped 0.3 percent to $14.75, having gained 15 percent over the past year.




© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Reserve Bank Holds Rate: Dollar Jumps As Potential Hike Wrong-Foots Traders

The New Zealand dollar jumped just over one US cent after the Reserve Bank's bias towards eventually hiking interest rates - rather than cutting them - wrong-footed traders who were more wary about global risks. More>>

ALSO:

Dolphins, Albatross, And... Four Endangered Sea Lions Dead In Nets In One Week

Forest and Bird: Four endangered NZ sea lions have been killed in commercial fishing nets in one week, making this the third day in a row endangered animals have been confirmed dead at the hands of the commercial fishing industry. More>>

ALSO:

Solar: Falling Battery Costs May Outstrip Transpower Projections

Falling solar and battery costs may already have overtaken prices assumed in Transpower’s latest modelling of the future power system, the Sustainable Energy Association of New Zealand says. More>>

ALSO:

Dire Deals: SAFE Salutes Short Shrift For Saudi Sheep

SAFE applauds the Government’s decision to cancel the controversial Saudi sheep deal, a plan by the previous Government which was to include a $10 million slaughterhouse in the Saudi desert. More>>

ALSO:

Nelson Fires: Extended Emergency

A combination of benign weather and outstanding fire management has seen the risk posed by the Pigeon Valley fire significantly reduced for some areas. More>>

ALSO: